Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

ANAB
AnaptysBio, Inc. Common Stock
stock NASDAQ

At Close
Jul 9, 2025 3:59:50 PM EDT
25.69USD+5.938%(+1.44)895,981
25.66Bid   25.75Ask   0.09Spread
Pre-market
Jul 9, 2025 9:13:30 AM EDT
24.30USD+0.206%(+0.05)977
After-hours
Jul 9, 2025 4:00:30 PM EDT
26.05USD+1.401%(+0.36)1,209
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsMore
open chart   
open chart   
Market Cap
756.55M
CEO
Hamza Suria
Headquarters
San Diego, California, USA
Industry
Biotechnology
Next Earnings
Aug 11, 2025 (33d)
Related
MNTAMLNTXLV
ANAB Stats
Avg. Vol. 10 Day
508,810
Avg. Vol. 30 Day
689,499
Employees
60
Market Cap
756,547,772
Shares Out.
29,380,496
On/Off Exchange
57%/43%
6 Month Beta
0.51
1 Year Beta
0.76
2 Year Beta
0.77
3 Year Beta
0.78
52 Week Low
12.21
52 Week High
41.31
SMA50
21.93
SMA200
21.40
1 Week
+7.83%
1 Month
+11.04%
3 Month
+52.37%
6 Month
+81.21%
1 Year
-0.12%
2 Year
+25.30%
5 Year
+14.29%
Profile
founded in 2005, anaptysbio, inc. is a privately-held company focused on the generation of antibody therapeutics, and the leader in the use of somatic hypermutation (shm) for antibody discovery and optimization. anaptysbio is building a pipeline of novel therapeutic antibody product candidates, including differentiated programs in cancer immunotherapy, inflammation, muscle wasting disorders, fibrosis and antibody-drug conjugate applications. anaptysbio's proprietary shm-xel platform, which couples fully human antibody libraries with in vitro somatic hypermutation (shm) in mammalian cells to generate high affinity lead candidates, replicates key features of the human immune system and overcomes limitations of prior antibody technologies. by harnessing the natural mechanism of antibody maturation under controlled conditions, shm-xel allows for the selection of optimal antibody properties such as high affinity, function, cross-reactivity, epitope diversity and manufacturability. the c

ANAB Stock Summary

AnaptysBio, Inc. Common Stock (NASDAQ:ANAB) stock price today is $25.69, and today's volume is 895,981. ANAB is up 5.938% today. The 30 day average volume is 689,499. ANAB market cap is 756.55M with 29,380,496 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC